CYCN — CYCLERION THERAPEUTICS INC
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 22 家机构在其最新 13F 申报中持有 CYCN(CYCLERION THERAPEUTICS INC),合计申报市值 $11.34M,对应 3.34M 股。按股数计算较上季度增持 436.4%(+662.16K 股),申报市值环比上升 1083.0%。持仓集中度较高:前五大持有人占申报市值的 91.9%,前十大的集中度为 98.1%。
与上一季度相比,10 家新建仓位、3 家加仓、3 家减仓、5 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
CYCLERION THERAPEUTICS INC(CYCN)的主要机构持有人包括 Kalehua Capital Management LLC、Fidelity Management & Research (FMR)、Balyasny Asset Management,按 13F 申报市值在本页 56 家持有人中排名居前。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q2 2026 | 22 | 3.34M | $11.34M | +436.4% |
| Q1 2026 | 17 | 161.92K | $249.03K | +48.8% |
| Q4 2025 | 19 | 296.25K | $376.26K | +16.0% |
| Q3 2025 | 16 | 215.22K | $495.03K | -2.7% |
| Q2 2025 | 16 | 362.81K | $1.06M | -2.8% |
| Q1 2025 | 18 | 373.39K | $931.70K | +0.5% |
| Q4 2024 | 19 | 382.07K | $1.23M | -28.0% |
| Q3 2024 | 15 | 1.04M | $2.70M | -0.7% |
表内 8 个季度中,机构持股合计增加 221%(Q3 2024 → Q2 2026);单季变动最大的是 Q1 2026(+48.8%)。
前 25 大机构持仓人(Q2 2026) — 22 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 1.65M | $5.60M | 3.22% | 新进 | |
| 649.55K | $2.20M | 0.00% | 增持 | |
| 317.51K | $1.08M | 0.00% | 新进 | |
| 298.76K | $1.01M | 0.06% | 新进 | |
| 156.89K | $531.86K | 0.02% | 新进 | |
| 59.80K | $202.71K | 0.00% | 增持 | |
| 45.85K | $155.47K | 0.00% | 新进 | |
| 45.85K | $155.47K | 0.00% | 减持 | |
| 30.91K | $104.80K | 0.00% | 增持 | |
| 24.31K | $82.41K | 0.08% | 新进 | |
| 22.05K | $74.00K | 0.00% | 新进 | |
| 16.80K | $56.94K | 0.00% | 持有 | |
| 11.72K | $39.74K | 0.00% | 新进 | |
| 7.35K | $24.93K | 0.00% | 持有 | |
| 3.13K | $10.63K | 0.00% | 减持 | |
| 1.85K | $6.27K | 0.00% | 新进 | |
| 192 | $651 | 0.00% | 持有 | |
| 130 | $440 | 0.00% | 持有 | |
| 100 | $339 | 0.00% | 持有 | |
| 87 | $295 | 0.00% | 新进 | |
| 72 | $244 | 0.00% | 持有 | |
| 4 | $14 | 0.00% | 减持 |
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q1 2026 — 17 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 84.55K | $129.80K | 0.00% | 增持 | |
| 18.26K | $28.03K | 0.00% | 新进 | |
| 16.80K | $26.04K | 0.00% | 持有 | |
| 16.14K | $24.77K | 0.00% | 新进 | |
| 10.00K | $15.50K | 0.00% | 新进 | |
| 7.35K | $11.29K | 0.00% | 新进 | |
| 4.74K | $7.28K | 0.00% | 持有 | |
| 3.39K | $5.26K | 0.00% | 增持 | |
| 192 | $295 | 0.00% | 持有 | |
| 130 | $201 | 0.00% | 持有 | |
| 100 | $155 | 0.00% | 持有 | |
| 100 | $155 | 0.00% | 持有 | |
| 89 | $137 | 0.00% | 减持 | |
| 72 | $112 | 0.00% | 持有 | |
| 5 | $8 | 0.00% | 持有 | |
| 4 | $6 | 0.00% | 新进 | |
| 1 | $2 | 0.00% | 持有 |
Q4 2025 — 19 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 115.60K | $146.82K | 0.00% | 持有 | |
| 43.30K | $55.01K | 0.00% | 增持 | |
| 41.55K | $52.77K | 0.00% | 增持 | |
| 28.30K | $35.94K | 0.00% | 新进 | |
| 23.49K | $29.83K | 0.00% | 持有 | |
| 16.80K | $21.33K | 0.00% | 持有 | |
| 10.03K | $12.73K | 0.00% | 新进 | |
| 8.20K | $10.42K | 0.00% | 新进 | |
| 4.74K | $6.02K | 0.00% | 持有 | |
| 3.15K | $4.01K | 0.00% | 增持 | |
| 376 | $478 | 0.00% | 增持 | |
| 192 | $244 | 0.00% | 持有 | |
| 130 | $165 | 0.00% | 持有 | |
| 107 | $136 | 0.00% | 增持 | |
| 100 | $127 | 0.00% | 持有 | |
| 100 | $127 | 0.00% | 持有 | |
| 72 | $91 | 0.00% | 新进 | |
| 5 | $6 | 0.00% | 持有 | |
| 1 | $2 | 0.00% | 减持 |
Q3 2025 — 16 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 116.16K | $267.16K | 0.01% | 持有 | |
| 37.16K | $85.49K | 0.00% | 增持 | |
| 23.49K | $54.03K | 0.00% | 持有 | |
| 16.80K | $38.63K | 0.00% | 持有 | |
| 13.29K | $30.57K | 0.00% | 新进 | |
| 4.75K | $10.92K | 0.00% | 持有 | |
| 2.33K | $5.35K | 0.00% | 减持 | |
| 649 | $1.49K | 0.00% | 持有 | |
| 192 | $442 | 0.00% | 持有 | |
| 130 | $304 | 0.00% | 持有 | |
| 100 | $230 | 0.00% | 持有 | |
| 100 | $230 | 0.00% | 持有 | |
| 49 | $113 | 0.00% | 减持 | |
| 22 | $50 | 0.00% | 减持 | |
| 5 | $12 | 0.00% | 新进 | |
| 5 | $12 | 0.00% | 持有 |
Q2 2025 — 16 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 155.19K | $451.59K | 100.00% | 减持 | |
| 116.16K | $338.01K | 0.02% | 持有 | |
| 32.73K | $95.29K | 0.00% | 增持 | |
| 23.49K | $68.36K | 0.00% | 持有 | |
| 16.80K | $48.88K | 0.00% | 持有 | |
| 9.73K | $28.31K | 0.00% | 减持 | |
| 4.74K | $13.79K | 0.00% | 减持 | |
| 2.76K | $8.04K | 0.00% | 增持 | |
| 649 | $1.89K | 0.00% | 持有 | |
| 192 | $559 | 0.00% | 减持 | |
| 130 | $378 | 0.00% | 持有 | |
| 100 | $291 | 0.00% | 持有 | |
| 100 | $291 | 0.00% | 持有 | |
| 24 | $70 | 0.00% | 增持 | |
| 11 | $32 | 0.00% | 持有 | |
| 5 | $15 | 0.00% | 持有 |
Q1 2025 — 18 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 164.78K | $411.94K | 100.00% | 持有 | |
| 116.16K | $290.39K | 0.02% | 持有 | |
| 31.60K | $78.09K | 0.00% | 减持 | |
| 23.49K | $58.02K | 0.00% | 持有 | |
| 16.80K | $41.99K | 0.00% | 持有 | |
| 13.00K | $32.50K | 0.00% | 增持 | |
| 4.94K | $12.20K | 0.00% | 增持 | |
| 1.05K | $2.63K | 0.00% | 减持 | |
| 649 | $1.62K | 0.00% | 持有 | |
| 540 | $1.33K | 0.00% | 持有 | |
| 130 | $325 | 0.00% | 持有 | |
| 100 | $250 | 0.00% | 持有 | |
| 100 | $250 | 0.00% | 持有 | |
| 20 | $50 | 0.00% | 持有 | |
| 19 | $48 | 0.00% | 持有 | |
| 11 | $28 | 0.00% | 持有 | |
| 5 | $12 | 0.00% | 持有 | |
| 1 | $3 | 0.00% | 持有 |
新建仓(Q2 2026)
- Kalehua Capital Management LLC 1.65M 股 · $5.60M
- Balyasny Asset Management 317.51K 股 · $1.08M
- ADAR1 Capital Management, LLC 298.76K 股 · $1.01M
- BRAIDWELL LP 156.89K 股 · $531.86K
- GEODE CAPITAL MANAGEMENT, LLC 45.85K 股 · $155.47K
- Rangeley Capital, LLC 24.31K 股 · $82.41K
- HRT FINANCIAL LP 22.05K 股 · $74.00K
- DIMENSIONAL FUND ADVISORS LP 11.72K 股 · $39.74K
- Tower Research Capital LLC (TRC) 1.85K 股 · $6.27K
- BARCLAYS PLC 87 股 · $295
完全清仓(较上季)
- Kovack Advisors, Inc. 卖出 10.00K 股 · $15.50K
- MAI Capital Management 卖出 100 股 · $155
- Citigroup Inc 卖出 89 股 · $137
- Caitong International Asset Management Co., Ltd 卖出 4 股 · $6
- Morgan Stanley 卖出 1 股 · $2
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kalehua Capital Management LLC | 1.65M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Fidelity Management & Research (FMR) | 649.55K | 4.74K | 4.74K | 4.75K | 4.74K | 4.94K | 4.74K | 157.64K | 161.42K | 162.33K | 162.85K | 164.55K | 164.95K | 3.39M | 3.42M | 3.41M | 2.54M | 2.62M | 2.62M | 2.65M |
| Balyasny Asset Management | 317.51K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ADAR1 Capital Management, LLC | 298.76K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| BRAIDWELL LP | 156.89K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Citadel Advisors | 59.80K | 18.26K | — | — | — | — | — | — | — | — | — | — | — | 187.80K | 251.20K | 253.35K | 240.50K | 143.00K | 323.73K | 284.28K |
| GEODE CAPITAL MANAGEMENT, LLC | 45.85K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 45.85K | 84.55K | 43.30K | 37.16K | 32.73K | 31.60K | 31.82K | 33.91K | 33.98K | 32.08K | 31.26K | 30.75K | 29.72K | 592.24K | 586.74K | 583.82K | 573.69K | 583.38K | 565.84K | 490.66K |
| VANGUARD CAPITAL MANAGEMENT LLC | 30.91K | 16.14K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Rangeley Capital, LLC | 24.31K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| HRT FINANCIAL LP | 22.05K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| BlackRock Inc | 16.80K | 16.80K | 16.80K | 16.80K | 16.80K | 16.80K | 16.80K | 16.80K | — | — | — | — | — | — | — | — | — | — | — | — |
| DIMENSIONAL FUND ADVISORS LP | 11.72K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 7.35K | 7.35K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| UBS Group AG | 3.13K | 3.39K | 376 | 49 | 9.73K | 13.00K | 9.67K | 145 | 2.71K | 2.52K | 2.23K | 276 | 186 | 14.25K | 18.21K | — | — | 3.65K | — | 3.54K |
| Tower Research Capital LLC (TRC) | 1.85K | — | 3.15K | 2.33K | 2.76K | 1.05K | 2.44K | 1.08K | 1.46K | 33 | — | — | — | — | — | — | — | — | — | — |
| GROUP ONE TRADING LLC | 192 | 192 | 192 | 192 | 192 | 540 | 540 | 540 | 540 | 540 | 540 | 540 | — | — | — | — | — | — | — | — |
| OSAIC HOLDINGS, INC. | 130 | 130 | 130 | 130 | 130 | 130 | 130 | — | — | — | 187 | 188 | — | — | — | — | — | — | — | — |
| Activest Wealth Management | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | — | — | — | — | — | — | — | — | — | — | — |
| BARCLAYS PLC | 87 | — | — | 5 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
常见问题
Which funds hold CYCN?
As of 2026-Q2, 22 institutional funds reported holding CYCN (CYCLERION THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $11.34M.
How many shares of CYCN do institutions own?
13F filers reported 3.34M shares of CYCN, worth $11.34M in aggregate at the end of 2026-Q2.
Is institutional ownership of CYCN rising or falling?
Share counts moved +436.4% versus the prior quarter — accumulation.
Who are the top institutional holders of CYCN?
The largest 13F holders are Kalehua Capital Management LLC, Fidelity Management & Research (FMR), Balyasny Asset Management, ADAR1 Capital Management, LLC, Slate Path Capital LP; the top 25 are ranked at the top of this page.
Who are the major shareholders of CYCLERION THERAPEUTICS INC?
The major shareholders of CYCLERION THERAPEUTICS INC (CYCN) by reported 13F value are Kalehua Capital Management LLC, Fidelity Management & Research (FMR), Balyasny Asset Management, ADAR1 Capital Management, LLC, Slate Path Capital LP, among 56 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.